The European Association of Hospital Pharmacists (EAHP) cordially invites you to send your options for exhibition space for the 23rd Congress of the EAHP, which will be held from 21-23 March 2018 in Gothenburg, Sweden. To view and select your stand, the floor plan may be found here.
The European Association of Hospital Pharmacists (EAHP) Congress exhibition offers a unique opportunity to showcase your institution and products to a captive audience of up to 4.000 hospital pharmacy professionals from Europe and abroad.
Recognised as the largest Congress in Europe, and the second largest Congress in the world for hospital pharmacists, the EAHP Congress grants you exclusive access to your core audience. Generate valuable leads, gain visibility, and engage with attendees who are looking for your innovative solutions in critical areas of hospital pharmacy.
For more information about how your organisation can participate in the EAHP Congress exhibition, or to reserve your exhibition space today, please contact us at exhibition[at]eahp[dot]eu.
The exhibition contract for the 23rd Congress of the EAHP is now available! Click HERE to download.Completed contracts can be sent to exhibition[at]eahp[dot]eu.
Download it HERE
Lead RetrievalLead retrieval order form - Click HERE to download. Please note that the information obtained from the scanners may not always be complete depending on whether the group administrators entered all participant details.
Download the guidelines HERE. DHL will handle all shipments, storage and onsite services for exhibitors this year.
2018 Gothenburg, Sweden - 23rd Congress of the EAHP
EXHIBITOR LISTING HERE
EXHIBITION FLOOR PLAN
OVERALL CONGRESS CENTRE FLOOR PLAN
As a service to both participants and exhibitors, EAHP provides you a preview of what will be happening during the congress exhibition.
This page will be updated on a regular basis with information from our exhibitors who wish to participate.
Accord Healthcare is the international arm of Intas Pharmaceuticals Ltd., with commercial operations in more than 80 countries globally and close to 60 EMENA markets. The first Accord commercial operations in Europe were recorded in 2008 in the United Kingdom. Currently, its portfolio comprises 423 generic INNs, including 50 novel Added Value Products.
Accord's vision is to be involved in all aspects of bringing pharmaceuticals to patients. Accord activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.
The need for pre-filled syringes in the hospital is growing, due to increased IV-drug safety risks for patients and hospital staff, i.e. administration of the wrong drugs, contamination of drugs, calculation mistakes in preparing drugs, and exposure to hazardous drugs.
Added Pharma presents practical solutions for the safe filling and labelling of large quantities of syringes in the hospital pharmacy with the help of its syringe filling machine and its large volume (1000ml to 5000ml) sterile IV-drug solution bag. You are more than welcome for a demonstration in our stand #23. You can also contact us via email (info[at]addedpharma[dot]com) or telephone (+31-412-627700)
Laboratoire Aguettant SAS is a pharmaceutical company dedicated to the development, manufacturing and commercialization of essential hospital medicines.
Its expertise in developing innovative injectable drugs and innovative administration systems (e.g. pre-filled syringes and pens) makes Aguettant a duly recognized player in critical care, anesthesiology, micronutrients and neurology. The company has a strong commercial infrastructure in Europe through its subsidiaries and elsewhere in the world through its international distributors.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Amgen was one of the first companies to recognize the potential of modern biotechnology in developing valuable medicines for patients – and to assemble the diverse set of skills necessary to advance from textbook to applied science. Today, we are applying our deep scientific capabilities from more than three decades of experience to the development of biosimilars and continuing our legacy of providing patients with vital medicines. We currently have a robust pipeline with several biosimilar molecules in development which target some of the most complex and important oncology and inflammation antibody biologics.
ARxIUM delivers best-in-class technology and unparalleled expertise focused on helping pharmacies of all sizes improve safety, productivity and efficiency.
We provide scalable, comprehensive pharmacy solutions – from drug order to delivery, prescription to patient – for every segment of the pharmacy market including but not limited to health systems, long-term care, retail and central processing.
Recognized for quality and integrity, our offerings are also supported by unmatched industry knowledge. Our solutions include automated IV compounding, compliance packaging management, inventory control and storage, workflow and scheduling software, vial-filling automation, expert consultation, product / workflow design and much more.
Contact us today to learn how ARxIUM can advance your clinical, operational and financial performance.
Using advanced spectroscopic technology that addresses the challenges of identifying and quantifying medications in difficult-to-monitor and critical environments, B&W Tek is proud to present the i-QCRx.
The i-QCRx provides near real-time and precise identification and quantification of cytotoxins, narcotics, antibiotics and other active pharmaceutical compounds in buffer solutions. It is ideal for use in hospital pharmacies, cancer treatment centers, compound pharmacies, CROs and pharmaceutical companies.
B&W Tek is the global leader in innovative mobile spectroscopy solutions. We utilize our own key building blocks consisting of spectrometers, light sources, sampling accessories and software capabilities to produce portable and handheld spectroscopy and laser instrumentation. B&W Tek provides Raman, LIBS, UV-Vis and NIR solutions for the pharmaceutical, biomedical, physical, chemical, safety, security and research communities.
New Concepts for safer Infusion Therapy
B. Braun, a globally operating family owned company with more than 43,000 employees. With innovative & state-of-the-art products focused on clinical safety, B. Braun leads the changing demands in health care around the world.
Through exchanging knowledge with its customers, B. Braun helps to improve treatments and working procedures in hospitals and medical practices and to increase the safety of patients, pharmacists, doctors and nursing staff.
Baxter International Inc. provides a broad portfolio of essential hospital and renal products, including home, acute and in-center dialysis: sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery and anesthetics; and pharmacy automation, software and services.
The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. www.baxter.com
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of healthcare and agriculture. Its products and services are designed to benefit people and improve their quality of life.
At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.
The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has 65,000 employees and a presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. http://www.bd.com/.
BIQ Heath Solutions develops mobile software for healthcare based on barcoding technology with the use of Android OS handheld devices. We deliver high-end solutions for nurses that increase Patient Safety at the bedside as well as increased efficiency in the product supply chain through higher inventory control.
Our latest release was MAPP®, an Android based Mobile Application Platform that combines all nursing activities into a single handheld device, not only providing increased mobility and productivity but reassuring Patient Safety through Barcode Scanning. Actions performed on MAPP® are automatically integrated with HIS and patient EMR. Apps such as validation of medication administration, safe blood transfusion, ward stock manage or record nursing procedures are accessible in MAPP®.
Our solutions are present worldwide and marketed through our distributor/partner network that we wish to broaden in EAHP. Please visit us at stand 56.
In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb.
This global alliance combines Bristol-Myers Squibb's long-standing strengths in cardiovascular drug development and commercialization with Pfizer's global scale and expertise in this field.
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for.
Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.
Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the "Making More Health" initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees' different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.
More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report:http://annualreport.boehringer-ingelheim.com.
BTC Medical Europe is an Italian SME leader in the production of drug delivery devices, collection and re-infusion of blood and medical devices for pharmaceutical companies.
Thanks to the strong competence on clinical pharmacy BTC developed OncoMix®: a set of products that is part of a complete closed-loop system able to guarantee the highest level of security, when dangerous drugs are involved, for the clinical personnel and for the patient.
BTC Medical Europe can support the needs of pharmacologists, lab technicians and nurses with a professional 360 degrees approach from the initial contact down to the post sales support.
Within the years, BTC has been building a series of important and strong partnerships with other major brands in oncology and operates with a carefully managed network of local partners covering their local markets.
The company has been founded in 2006 in Valeggio sul Mincio (VR) and grew quickly thanks to the skills and the competence of the available. In December 2016, 75% of BTC Medical Europe's has been acquired by Sidam Srl and thus entered the Synopo Group, strengthening its presence in the market.
The strong optimization of the concept design phase, with advanced 3D solutions, flow and FEM simulation software and rapid prototyping, can guarantee high-quality projects and products. We offer innovative solutions and components thanks to a highly-qualified production and design team, operating in high-quality assembly environments (ISO 7 White Room) and using sophisticated techniques.We also provide superior contractual solutions to companies operating in the pharmaceutical and medical devices industry, with particular attention to the needs of customers and patients.
BTC Medical Europe SrlVia del Lavoro, 1037067 Valeggio sul Mincio (VR)tel +39 045 7952364/+39 045 7952360fax +39 045 7951031http://www.btcmedicaleurope.cominfo[at]btcmedicaleurope[dot]it
The right medicine for your patient might not be available locally for many reasons, including medicines:
· In a clinical trial
· Not commercially available, globally or in your country
· Unavailable due to medicine shortages
· Withdrawn from the market
The use of unlicensed, imported medicines plays an essential role in ensuring the best possible patient outcomes.
Clinigen is the global leader in providing ethical, compliant access to unlicensed or unavailable medicines, meeting the demands of pharmacists and physicians around the world treating patients with unmet medical need.
Comecer is an Italian company that designs and manufactures high-technology equipment in the field of nuclear medicine, isolation technology for pharmaceutical production and nuclear power plant equipment.
Our aim is to continuously increase the quality of the product production, the safety of technicians and researchers and the value for patients worldwide. We strive to contribute to progress through the development of innovative technologies and sustainable solutions, according to the latest GMP (Good Manufacturing Practice) regulations. We continue to implement large investments in Research & Development in order to be at the forefront and maintain a technological advantage in the sector. In the field of isolation technology for aseptic processing of pharmaceutical products Comecer develops standard and tailored solutions for the production of isolators for the treatment of toxic and non-toxic substances to be used in pharmaceutical production companies, in university research centres, in hospitals, and in small as well as in large industrial groups worldwide. We gained experience in manual and semi-automatic sterile processing of cytotoxic antiblastic drugs in hospital pharmacies. All systems are tested and undergo a comprehensive series of validation checks according to the applicable standards and norms. The "Safety First" Code of Ethics applies inside Comecer, which translates into quality of materials and processes and allows Comecer to qualify its products in accordance with the highest standards in the sector.
Software company specialist in hospital solutions : surgery, sterilization systems, computerized physician order entry, drug processing management, chemotherapy safety system.
Dedalus Group is the first healthcare software organization in Italy and one of the major in world. Dedalus Group implemented its expansion by leveraging the full functional coverage of all ICT needs of every healthcare system public and private.
Dedalus Group worldwide and the Group is currently present in 25 Countries, such as France, Spain, UK, USA, Latin America, China, Middle East , North and South Africa.
Fields of application:
Equashield is a leading provider of Closed System Transfer Devices (CSTDs), clinically proven to protect healthcare professionals from hazardous drug exposure.
Incorporating a pioneering design, the company’s flagship device, EQUASHIELD® II, covers more routes of exposure than alternative systems by preventing: contamination of syringe plungers, drug residuals on connector surfaces as well as exposure to drug vapor. No CSTD is faster to deploy or easier to use than EQUASHIELD®. The EQUASHIELD system has been cleared by the FDA under the ONB product code and substantiated in FDA-cleared labeling as preventing microbial ingress for up to seven days.
French designer and manufacturer of isolators, EuroBioConcept is specialized in bio containment solutions (RTP and BCS Class III) for pharmacies, pharmaceuticals industries and research centers.
With more than 20 years in technology of containment, our team provides you customized solution on a very safe way. Based in Paris, EuroBioConcept is to be found all over the world, with distributors and partner companies in sales and service.EuroBioConcept protects both products and operators. www.eurobioconcept.fr
Some hospital pharmacists want to prepare customized pharmaceutical products themselves. Others would like to be supported during this process with innovative concepts, vehicles and formulations. In certain situations, however, hospital pharmacists are not always able to compound customized products themselves due to time, equipment or facility constraints. No matter what the situation, Fagron strives to meet the needs of hospital pharmacists with expert advice and tailored solutions to help improve the lives of patients every day.
Fagron is active in the following segments of pharmaceutical compounding:
Visit the Fagron booth #52 and find out what we can do for you! To contact us, please visit www.fagron.com for (contact) information.
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products.
Within transfusion technologies, Fresenius Kabi offers products for whole blood and blood components collection and processing as well as for transfusion medicine and cell therapies.With our corporate philosophy of "caring for life", we are committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face. For more information, visit www.fresenius-kabi.com..
GPI is based in Trento and its revenues in 2015 were of more than EUR 98 millions, it has over 2,600 employees and it is the reference technology partner in the Health and Social market in the Trentino region. Founded in 1988 by Fausto Manzana, it boasts numerous branches throughout the country and abroad, especially in Germany, Brazil and the Middle East.
Thanks to an increasingly advanced technology in social and health informatics and new hi-tech services for health, GPI excels in matching the needs of transformation and the innovative drive of its many clients in the public and private sector. The Group's strong growth was driven by significant investments in its R & D Center, which, in partnership with leading universities research centres both in the Trentino region and in Italy, aims at disseminating scientific, technological, functional and process knowledge applied to the e-health, e-welfare and well-being sectors. The Group value proposition combines expertise in IT as well as consulting and project capabilities that enable to work in different business areas: Information Systems, Services for Healthcare, Logistics and Robotic automation, ICT Professional Services and Electronic Money. In the last four years the Group has grown thanks to the acquisition of companies with complementary or adjacent business and the development of business in Italy and abroad. The IPO is aimed at strengthening its presence in the international and national territory. The common shares and warrants of GPI from December 29, 2016 were admitted to negotiations for the AIM Italy / Alternative Market of the capital organized and managed by the Italian Stock Exchange.
Ordinary shares ISIN: IT0005221517 - ISIN "Warrant GPI SpA": IT0005221475
Grifols is a global healthcare company with a 70-year legacy of improving people's health and well being through the development of life-saving plasma medicines,
diagnostic systems and hospital pharmacy products. The company is present in more than 100 countries worldwide and is headquartered in Barcelona, Spain. Grifols is a leader in plasma collection with a network of 150 plasma donor centers in the U.S., and a leading producer of plasma-derived biological medicines. The company also provides a comprehensive range of transfusion medicine, hemostasis, and immunoassay solutions for clinical laboratories, blood banks and transfusion centers, and is a recognized leader in transfusion medicine.
For more information visit www.grifols.com
Both BIQ and H+H system are together to provide complete logistic workflow solutions ensuring full control and traceability of all items used in the hospital.
Our solutions combine storage optimization with item tracking through barcoding providing an investment payback in hospitals adopting this solution.
Haemopharm was born in the 70's from a family company already present in the medical devices industry and specialized in the production of flexible bags, components and delivery systems for different medical and pharmaceutical applications.
Haemopharm products are used in hospitals, pharmacies and home care, starting from empty bags used as containers of the infusion solutions, to the multi compartment bags and delivery systems used for different therapeutic applications such as pharmacy compounding, drug reconstitution, oncology, dialysis, nutrition, cells and tissue preservation, ozone therapy and ophthalmology. Haemopharm products are customizable according to the customer needs and this represents the added value of the Company: Haemopharm supports its clients from the feasibility assessment, according to the therapeutic requirements, through research and design of special solutions, until their final fulfillment.
hameln is a leading supplier of high quality generic medicines, specialising in supplying parenteral formulations in anaesthetics and critical care. Our portfolio contains a variety of products, ranging from water for injections to sedatives, anaesthetics, analgesics and antidotes.
Everything we do is driven by the understanding we are all patients, so our team of dedicated employees is committed to delivering quality, consistency and reliability throughout everything we do.
Pharmacists and other healthcare professionals rely on our expertise and experience in the area of parenteral formulations. Our labelling is constantly evolving using intelligent packaging design to help reduce the risk of medication errors. We have also developed standardised drug infusion concentrations for use (Ready-to-Use solutions) in intensive care units. We listen, we learn and we turn ideas into solutions.
Today, our products are available in more than 40 countries throughout the world.
For more information, please visit us in the exhibition hall at stand 28.
Having introduced new and innovative medical technologies highlighting previously overlooked or accepted clinical threats and hazards - ICU Medical continues to pioneer products which improve clinical efficiency, increase patient and practitioner safety and help optimise patient health outcomes.
Today, the preparation of combined infusion solutions for intensive care patients faces users with highly intractable tasks.
Exactly defined quantities of different substances must be commingled under aseptic conditions.
With our new range of Medi Mix compounders we aim to be the leading partner for every pharmacy.We offer semi and fully automatic compounders as well as a complete range of disposables.Environment-friendly MPE not absorbed by any drug is offered as an alternative to the noDOP tube as a new development of manufacturing technology.Injection ports, check valves, and a minimum of connections provide a high degree of safety.For more information, visit our website www.impromediform.de.
For over 45 years, IMI has worked closely with pharmacists and compounding professionals to create innovative sterile products that meet very specialized needs.
A prime example is the Prep-LockTM Tamper Evident Syringe Cap technology that has become a standard among hospital pharmacies and outsource compounders everywhere. In addition, IMI has developed long standing relationships with some of the biggest names in healthcare. Through these partnerships and directly, IMI is delivering the kind of high quality and high value products that pharmacy operations demand. All IMI products are manufactured in the USA under the strictest quality standards at their FDA licensed, ISO 13485 certified facility.
Founded in 1912, the International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists and pharmaceutical scientists and is in official relations with the World Health Organization (WHO).Through its 140 Member Organisations FIP represents and serves more than four million pharmacists around the world.
Throughout its over 100 year history, FIP's priorities have expanded both literally and figuratively to meet the needs and expectations of the profession in expanding healthcare services and integrating emerging scientific developments. Changes in pharmacy and the emergence of Pharmacy Practice as a cornerstone of the profession have lead FIP to become globally visible for its advocacy on behalf of the role of the pharmacist in the provision of healthcare, while still maintaining its grounding in the pharmaceutical sciences.
In parallel, the membership of FIP has evolved to become the most extensive global pharmacy and pharmaceutical sciences network. This network is continuing to expand its presence and influence through partnerships with some of the world’s leading healthcare, educational and scientific institutions.
This year FIP's annual World congress of pharmacy and pharmaceutical sciences will take place in Glasgow, UK, 2-6 September 2018 under the theme of: "Pharmacy: Transforming Outcomes! New ways for pharmacy to provide better patient care." The congress is accredited (ACPE and others). It's preceded by: Immunization training, Pharmacy Technicians symposium, Biosimilar workshop, the AIM Global Deans Forum and the Young Pharmacists Group Leadership Training. The FIP congress welcomes 4000 pharmacists from over 100 countries representing all fields of pharmacy. It's the global platform for networking and cross-fertilization.
With 20 years' experience in the design, manufacture and maintenance of isolators and customized isolation technology solutions, placing flexibility and technological innovation central to its corporate policy, JCE BIOTECHNOLOGY offers a wide range of isolators, generators for surface sterilization and secure transfer systems, including a wide range of accessories and disposables.
In addition to applications in pharmaceutical industries, biotechnologies and laboratories & research institutions, these solutions are also aimed at specific applications of hospital pharmacy including indeed : preparation of anti-cancer injectable drugs (cytotoxics, monoclonal antibodies), preparation of parenteral nutrition, preparation of capsules and pediatric isolation systems, secure transfer of sterile products and substances, wastes and fluids, bio-decontamination with hydrogen peroxide at low temperature and without residue, etc.
HD Medi was formed in 2010 as a joint venture between the Dutch company, Dijkstra Vereenigde B.V. and the South Korean company, JVM Ltd. Both companies were active in the area of packaging machines; Dijkstra first for food and then for pharmacies; JVM in medicine dispensing systems for pharmacies. In 2014, HD Medi became a fully owned subsidiary of JVM Ltd.
Today HD Medi is the European leader in automated pharmaceutical medicine dispensing machines, with more than 1000 installations in Europe and more than 10,000 worldwide.
We believe that every patient has the right to receive the correct medication – if it is one pill a day or if it is 10 pills a day. Patients should not have to worry if their pharmacy, hospital or caregiver is giving them the correct dosage at the correct time. Our products ensure that this worry is taken away and our solutions offer unparalleled accuracy and security.
LEVENTON A Werfen Company is a Spanish manufacturer of disposable medical devices located close to Barcelona. Since its foundation in 1979, LEVENTON has constantly focused on 3 main areas which are: Innovation, Quality and Service. The constant attention to these areas has allowed our company to globally expand by closely monitoring and following the market requirements.
LEVENTON has become a worldwide market leader in development, manufacturing and distribution of infusion medical devices, offering solutions and benefits very appreciated for patients and professionals for all infusion therapies.
Macopharma is one of the key players in the medical device industry for blood transfusion, solution bags and biotherapy.
Their growth has always been driven by major innovations. These innovations are the result of substantial investments in research and development, as well as cooperation with customers and partners: blood centres, research laboratories, hospitals...
For each of these 3 fields, Macopharma offers a range of products and services for each step of the processes.
With 2300 employees, 4 plants (2 in France, 1 in Poland and 1 in Tunisia) and worldwide presence in nearly 100 countries, Macopharma aims at offering innovative solutions and quality products to optimise therapeutic practices and make them safer.
MedEye was founded to improve medication safety in hospitals and care institutions.
Through a combination of innovative hardware and software and seamless integration with hospital information systems, the solution enables nurses to automatically verify medication at the bedside, ensuring that patients get the right medication, in the right dose and at the right time. MedEye is already deployed at several Dutch hospitals. We cordially invite you to our booth #19 or visit our homepage or visit our website https://MedEye.io/ (email: contact[at]MedEye[dot]io)
The Medi-Dose® unit dose packaging systems are efficient, inexpensive systems for in-house packaging and distribution of solid oral medication.
Medi-Dose provides tamper-evidence, ultraviolet inhibitance and moisture protection. No glass, metal, large capital expense or formal training is required. For more information, visit www.medidose.com.
MedXL is proud to contribute to improving the quality of life of patients by designing and manufacturing medical devices and prefilled syringes for biomedical and pharmaceutical industries worldwid
e. MedXL was founded 25 years ago and is based in Montreal Canada
MedXL is proud to introduce its PraxiMed™ System at the EAHP 2016.PraxiMed™ is an automated system for the preparation of medications in syringes and consists of:- PraxiPump™: Automated vial filler- PraxiFill™: Automated syringe filler- PraxiLabel™: Automated syringe labeller
For more information, please visit www.medxl.com.
For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information, visit www.msd.com and connect with us on Twitter, LinkedIn and YouTube.
NewIcon Oy is a Finnish company focusing on medical service automation. We develop, produce and sale automation systems for hospital and retail pharmacies.
NewIcon Oy offers varies solutions for drug logistics (storage and retrieval systems) and pharmaceutical compounding (IV medicines).
Our know-how and the technology that we use met the high standards of our customers and we head for continuous improvement. With years of experience, we can proudly offer a quality, serving customer in the years to come.
More information in website: www.newicon.fi or marja.jaurakkajarvi[at]newicon[dot]fi.
Omnicell is a leading provider of medication and supply automation and related business analytics.
At Omnicell, we’re inspired to create safer and more efficient ways to manage medications and supplies across all care settings. By automating what are often disconnected, manual, and at times dangerous processes, we’re helping to improve clinical and financial outcomes, allowing caregivers to focus on what’s most important—the patient.
We work with healthcare providers to drive operational efficiency by removing tedious tasks and waste.Regardless of distribution model, our solutions automate manual processes—including ordering, receiving, stocking, and picking medications.
Leveraging a unified platform, our inventory management solutions and services give visibility to opportunities to optimize workflows, monitor inventory, and reduce costs.
OPTEL GROUP, a certified B Corporation, is a leading multinational provider of traceability systems and aims to use its innovative technologies to create a better world.
The company's renowned solutions ensure the quality of consumer health products and help stop counterfeiting of pharmaceuticals and medical devices worldwide. OPTEL is also adapting its technologies to create efficiencies in various other sectors that can benefit from end-to-end traceability. Having served the pharmaceutical industry for nearly three decades, ensuring patient safety has always been at the heart of OPTEL's operations. OPTEL has now taken its commitment to healthcare even closer to people by extending its expertise and technologies to hospital pharmacies. OPTEL provides pharmacies with cutting-edge Track&Trace solutions that perform verification, decommissioning and reverting functionalities in accordance with the compliance requirements of the EU's Falsified Medicines Directive. OPTEL understands the responsibility that comes with caring for others and partners with key industry stakeholders to support them throughout the care continuum – from the manufacturing facility to the patient, and beyond. Learn more at www.optelgroup.com and www.optelhealthcare.com
Paxxo is Swedish based packaging company with a 40-year history.
Our business concept is to manufacture the unique endless bag system Longopac that, thanks to innovative, smarter waste management and packaging solutions, creates a better working environment for different segments. Our successes are possible because our products offer rational handling, a better working environment and low environmental impact. Our bag system is based on a strong, 3-layer polyethylene bag material which is folded into compact cassettes that today is sold in more than 35 countries. Our main product for hazardous waste handling is Pactosafe. It is a waste sealing unit for safe airtight sealing of cytotoxic waste, smelly waste and toxic laboratory waste.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value the discovery, development and manufacture of health care products.
Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.
Pharmacolog specialize in efficient solutions to prevent medication errors.
With our safety device DrugLog ®, you can quickly verify that the intravenous medication is accurate before it's given to the patient. DrugLog is a combination of hardware and software that through a patented process can identify the drug being prepared and verify its concentration, prior to patient infusion.
For more information, please visit http://www.pharmacolog.com.
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world. Integral to the Society since its inception in 1841, Pharmaceutical Press has been able to draw on relevant knowledge, research and influence to guide and inform the direction of its publishing programme.
Pharmaceutical Press publish a wide range of titles in print and digital formats, including Martindale, the British National Formulary (BNF), Stockley's Drug Interactions, and Remington. The two digital platforms: MedicinesComplete and BNF on FormularyComplete, offer comprehensive, flexible and cost-effective online solutions.
Sandoz, the generic pharmaceuticals and biosimilars business of Novartis, is a global leader in the rapidly growing generics industry.
Sandoz employs over 26,000 employees in more than 140 countries, offering broad range of over 1,000 high-quality, affordable products that are no longer protected by patents. With USD 9.6 billion in sales in 2014, Sandoz holds the #1 position globally in biosimilars as well as generic injectables, ophthalmics, dermatology and antibiotics.
Sinteco, established in 1984, is a leader in the designing and manufacturing of systems in industrial automation and for the hospital industry.
The Hospital Division develops solutions for the management of medicinal unit doses in the hospital field.
The solution to hospital needs is Athena: the modular and flexible system for pharmacies for the management of unit doses. This tool allows the distribution in pharmacies of personalized formulas or to group and identify, with the name of the patient, the prescribed medications. Athena has been realized in order to meet the real needs of any hospital structure. It is not a simple serial system (packaging-storing-delivering), but a network of automations where each component is connected to the others. This allows notable practical advantages, both economically and in terms of quality."
Simeks is the creater of STOCKART Automated Medication and Supply Management Systems. STOCKART is a process management solution focused on patient safety and cost reduction, using advanced technology.
STOCKART modules enable real-time monitoring of meds and supplies from hospital warehouses to pharmacies, wards and patients. By optimizing the clinical care and supply chain processes the modules improve patient safety and reduce hospital costs. All medical supplies and meds including IV liquids, narcotics and cold chain meds can be monitored within a hi-security environment. STOCKART modules have been designed to meet all needs of hospitals and can be customized according to any institution's needs. For more information please visit our website www.stockart.com.tr/en
The Ing. Sumetzberger GMBH. has been developing reliable pneumatic tube systems for the healthcare sector since 1983.
They offer fast, efficient, safe and fully automated transportation of laboratory samples, blood bottles and medication. At the 20th Congress of the EAHP Sumetzberger presents a highly effective combination of a pharmaceutical robot with a pneumatic tube system together with its partner Sinteco. Everyday hospital pharmacies are in demand to take care of the management of a great number of patients' medications. The fully automated pharmacy by Sumetzberger and Sinteco simplifies this process crucially. The handout of unit dose medications is done by a pharmaceutical robot and transported to the individual wards fully automatically via pneumatic tube system. This offers highly efficient management and transport of medications as well as greater transparency due to a multi-layered monitoring system.
The benefits at a glance:
Swisslog designs, develops, and delivers best-in-class automation for forward-thinking health systems, warehouses, and distribution centers. We offer integrated solutions from a single source – from consulting to design, implementation and lifetime customer service. Behind the company's success are 2 500 employees worldwide, supporting customers in more than 50 countries.
For a live demonstration, please visit us at Booth 35.
For more information, please go to swisslog.com/healthcare
Swisslog is a member of the KUKA Group, a leading global supplier of intelligent automation solutions. www.kuka.com
A global leader in the manufacture of flexible bags and connectors for the pharma industry with over 40 years of experience, make Technoflex the choice of many infusible drug manufacturers.
Our extensive R&D commitment to finding new materials and processes ensure new and novel solutions for our clients' bag needs. Empty bags for Chemotherapy, Parenteral nutrition, drug reconstitution, etc.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day.
Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com.
Truven Health Analytics delivers unbiased information, analytic tools, benchmarks, and services for healthcare professionals.
Hospitals, government agencies, clinicians, academic institutions and pharmaceutical companies have relied on us for more than 30 years. We combine our clinical expertise with innovative technology platforms to help improve the cost and quality of healthcare in 83 countries.Visit us at the Micromedex booth at stand #62 to learn more about how our solutions can improve patient safety.
Vygon is a world leader in the creation of high technology single-use medical devices, distributed throughout the world by our dedicated network of 27 subsidiaries and 331 integrated distribution partners.
Vygon offers an extensive range of products suitable for use in the following clinical departments: • Neonatology, nutrition & obstetrics • Intensive care • Anaesthesia & Emergency • Intravascular Therapies • Cardiovascular & Surgery For more information about our recent innovations, visit our website www.vygon.com.
There are times when a much needed licensed drug may not be available to you.
This can happen in the following circumstances:
If you are a Physician or Medical Institution and wish to gain access to an unlicensed or unavailable medication we can assist you with this. WEP Clinical can locate specific medications to suit your patients' needs and through our global network of suppliers and manufacturers, we provide a sophisticated medicines sourcing service.
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products.
Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2014 sales of $1.42 billion reflect the daily use of approximately 110 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.
Willach is a leading producer of storage and dispensing equipment for medicines at hospital and community pharmacies.
High quality Fama drawer and rack systems. Consis automatic storage and dispensing systems. Worldwide presence.
You are welcome at: www.willach.com
The EAHP Daily Dose made its congress debut at the Paris Congress in 2013 and has since become an absolute must-read for congress attendees. This daily newspaper provides a daily breakdown of speeches, seminars & workshops, and features exclusive interviews with speakers.
The Daily Dose is delivered directly to the hotel rooms of attendees staying in registered hotels on the first day of congress and distributed by hostesses on the first and second day of congress, so participants won’t miss out on any of the action!
The Newspaper provides a unique opportunity for companies and other organisations to:
Distributed to all congress delegates at registration, the branded bags provided by your company will not only give your brand increased visibility, but also serve as a convenient carrying case both during and after the congress! All congress printed materials will be inserted into the bags.
Help attendees stay connected during the congress by sponsoring the popular Cyber Café!
The free Cyber Café is the perfect place for delegates to check email, charge their devices, access the internet via desktop terminals, or catch up on the latest edition of the Daily Dose!
Branding provided by EAHP for cafe and the charging stations.
Place brochures, flyers or other promotional item in the congress bags which are distributed to all participants. We expect approximately 4.000 participants and will be able to provide you with a more accurate count by mid-February.
Is your organisation sponsoring a satellite event? If so, welcome congress attendees to your event with a PDF invitation featured on the congress programme schedule and satellite symposia section located on the EAHP website.
Sponsors now have the opportunity to do get in touch with EAHP congress participants before they arrive in Cannes, with pre-approved htm or text advertisements.
One little book, so much helpful information! The mini - programme book (size: closed: 105 x 148 mm - open: 210 x 148 mm) is handed out during congress registration and contains a daily schedule of the congress including seminars, workshops, satellite symposia, breaks, etc.
Your sponsorship includes :
-Inside front cover-Inside advertisement-Back cover
The poster exhibition and the oral poster communication session are the mainstay of the annual congress and only the best are selected!
Your sponsorship includes:- 4 roll-up banners, double sided.- Branded napkins - EAHP will have these made and distribute to the catering department for use during the poster area coffee breaks- Distribution of brochures or other promotion materials during the coffee breaks- Announcement of sponsorship of the coffee breaks through the public address system- Acknowledgement of sponsorship on the EAHP website and in the congress programme book, as well as on directional signage placed throughout the congress centre.
With more visitors from the health care community viewing the EAHP site, EAHP’s renewed website is a unique opportunity to increase your company’s visibility!
See below the various options to advertise online and improve your visibility on EAHP’s website:
Corporate logo, with hyperlink to company website, on EAHP Sponsors & Partners page (http://www.eahp.eu/sponsors-partners)Corporate logo, on EAHP congress page with hyperlink Skyscraper (Position: located on the right side of congress landing page)Skyscraper (Position: located on the right side of other internal pages)
Let us help you inform pharmacists in advance of your attendance, promote your symposium, or just help increase stand visits by placing an advertisement within the European Journal of Hospital Pharmacy, the official journal of the EAHP.
A 20% discount will be offered to all EAHP Exhibitors and Satellite sponsors!
Free and fast WiFi is a service that is prized by attendees and exhibitors alike. Keep everyone connected by with the exlusive WiFi sponsorship!
Don't miss out on the chance to promote your brand throughout the entire congress! Place an ad, invite delegates to your satellite symposium/exhibition space, on screens located in the registration foyer area or in the entry way to the exhibition hall.
This option is addressed to sponsors of satellite symposia who wish to have the session video recorded and integrated into a web cast to be posted on the EAHP web site.
To view examples, please follow this link: http://www.farmaactueel.nl/webcasts/extern/EAHP2013/Inleiding.htm
Do you wish to further promote your exhibition stand or satellite symposia? If so, you may purchase floor space per poster or roll-up banner.
NOTE: Sponsor banners may not be displayed without purchasing floor space with the exception of inside satellite symposia rooms.
For the below events, branding may consist of signage, napkins with your company logo, etc. Sponsors will be acknowledged in the congress programme book.
Opening Reception - 16th March, open to all participants.
Faculty Dinner - attended by presenters of scientific programme.
Tea/Coffee Break - to be served in the exhibition hall.
Pens and notepads - Promote your company even after the congress by providing pens and notepads which will be inserted in the congress bags.
Public announcement in congress centre - EAHP is offering the opportunity for your company to have a promotional announcement read over the loud speaker at the congress centre.
Meeting room/hospitality suites - EAHP is offering on-site rooms in the congress centre to be used as hospitality suites or meeting rooms.
Exhibition extended hours In Cannes - EAHP will be offering extended exhibition hours. Take a little extra time to meet with clients and visitors before the crowds arrive
For more information and rates, please contact exhibition[at]eahp[dot]eu .